Quantification of mRNA in whole blood by assessing recovery of RNA and efficiency of cDNA synthesis

被引:31
作者
Mitsuhashi, M
Tomozawa, S
Endo, K
Shinagawa, A
机构
[1] Hitachi Chem Res Ctr Inc, Irvine, CA USA
[2] Univ Calif Irvine, Dept Pathol, Coll Med, Irvine, CA 92717 USA
[3] Univ Tokyo, Dept Surg Oncol, Fac Med, Tokyo, Japan
[4] Hitachi Chem Co Ltd, Tokyo, Japan
[5] Hitachi Gen Hosp, Hitachi Ltd, Hitachi, Ibaraki, Japan
关键词
D O I
10.1373/clinchem.2005.048983
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background; Current gene expression analysis relies on the assumption that the isolated RNA represents all species of mRNA in proportions equal to those in the original materials. No system is available for absolute quantification of mRNA. Methods: We applied whole blood to 96-well filter-plates to trap leukocytes, Lysis buffer containing cocktails of specific reverse primers and known concentrations of synthetic external control RNA (RNA34) was added to filterplates, and cell lysates were transferred to oligo(dT)-immobilized microplates for hybridization. We then synthesized the cDNA in the oligo(dT)-immobilized microplates from these primer sites and used the cDNA for real-time PCR. RNA34 acted as a universal control, and gene amplification results were converted to quantities of mRNA per microliter of whole blood after the recovery of RNA34 in each sample was determined. Results: Under fully optimized conditions, both added RNA34 and native mRNA species exhibited -10% recovery from whole blood to real-time PCR. When whole blood was stimulated ex vivo, changes in gene expression as low as 30%-40% were detected with statistical significance, and the experimental CV were low (10%-20%). Conclusion: This new system to estimate mRNA copies per microliter of whole blood may allow standardization of gene-expression-based molecular diagnostics. (c) 2006 American Association for Clinical Chemistry.
引用
收藏
页码:634 / 642
页数:9
相关论文
共 31 条
[1]
ARTUSO M, 1995, ONCOGENE, V11, P1427
[2]
RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[3]
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]
NUCLEIC-ACID SEQUENCE-BASED AMPLIFICATION [J].
COMPTON, J .
NATURE, 1991, 350 (6313) :91-92
[5]
Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method [J].
de Vries, TJ ;
Fourkour, A ;
Punt, CJA ;
Ruiter, DJ ;
van Muijen, GNP .
MELANOMA RESEARCH, 2000, 10 (02) :119-126
[6]
LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL [J].
Eggesbo, JB ;
Hjermann, I ;
Hostmark, AT ;
Kierulf, P .
CYTOKINE, 1996, 8 (02) :152-160
[7]
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].
Furtado, MR ;
Callaway, DS ;
Phair, JP ;
Kunstman, KJ ;
Stanton, JL ;
Macken, CA ;
Perelson, AS ;
Wolinsky, SM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622
[8]
Monitoring of NFAT-REGULATED gene expression in the peripheral blood of allograft recipients: A novel perspective toward individually optimized drug doses of cyclosporine A [J].
Giese, T ;
Zeier, M ;
Schemmer, P ;
Uhl, W ;
Schoels, M ;
Dengler, T ;
Buechler, M ;
Meuer, S .
TRANSPLANTATION, 2004, 77 (03) :339-344
[9]
GILLIS S, 1980, J IMMUNOL, V124, P1954
[10]
β-actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels [J].
Glare, EM ;
Divjak, M ;
Bailey, MJ ;
Walters, EH .
THORAX, 2002, 57 (09) :765-770